From the Food and Drug Administration.
Nightingale
S L
SL
D000243:Adenosine Deaminase / Q000627:therapeutic use; D003952:Diagnostic Imaging; D005515:Food Labeling; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy*; D007223:Infant; D007225:Infant Food; D009965:Orphan Drug Production; D010599:Pharmacokinetics; D013025:Glycine max / Q000009:adverse effects*; D013810:Therapeutic Equivalency; D014481:United States; D014486:United States Food and Drug Administration
D000243:Adenosine Deaminase; C051409:pegademase bovine